3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors - Related Studies

Home

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

This study has been completed.

Study NCT00079014. Last updated on August 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Interventions listed in this trial
		doxorubicin hydrochloride
		triapine

2	Additional drug interventions recognized in this trial
		Doxorubicin

3	More general drug interventions related to this trial
		Antibiotics, Antineoplastic
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

4	Sponsors listed in this trial
		University of Wisconsin, Madison
		National Cancer Institute (NCI)